Annual Operating Profit
-$44.01 M
+$37.93 M+46.29%
31 December 2023
Summary:
Xeris Biopharma Holdings annual operaing income is currently -$44.01 million, with the most recent change of +$37.93 million (+46.29%) on 31 December 2023. During the last 3 years, it has risen by +$39.54 million (+47.32%). XERS annual operating profit is now -232.63% below its all-time high of -$13.23 million, reached on 31 December 2016.XERS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$12.89 M
-$4.71 M-57.48%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly operating income is currently -$12.89 million, with the most recent change of -$4.71 million (-57.48%) on 30 September 2024. Over the past year, it has dropped by -$7.98 million (-162.43%). XERS quarterly operating profit is now -177.33% below its all-time high of -$4.65 million, reached on 31 March 2017.XERS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$45.17 M
-$7.98 M-21.46%
30 September 2024
Summary:
Xeris Biopharma Holdings TTM operating income is currently -$45.17 million, with the most recent change of -$7.98 million (-21.46%) on 30 September 2024. Over the past year, it has increased by +$4.17 million (+8.46%). XERS TTM operating profit is now -871.52% below its all-time high of -$4.65 million, reached on 31 March 2017.XERS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.3% | -162.4% | +8.5% |
| 3 y3 years | +47.3% | +47.1% | +47.6% |
| 5 y5 years | +25.8% | +57.1% | +58.9% |
XERS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.8% | -162.4% | +73.3% | -21.5% | +64.6% |
| 5 y | 5 years | at high | +64.0% | -162.4% | +73.3% | -21.5% | +64.6% |
| alltime | all time | -232.6% | +64.0% | -177.3% | +73.3% | -871.5% | +64.6% |
Xeris Biopharma Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.89 M(+57.5%) | -$45.17 M(+21.5%) |
| June 2024 | - | -$8.19 M(-42.5%) | -$37.19 M(-17.3%) |
| Mar 2024 | - | -$14.24 M(+44.8%) | -$44.98 M(+2.2%) |
| Dec 2023 | -$44.01 M(-46.3%) | -$9.84 M(+100.3%) | -$44.01 M(-10.8%) |
| Sept 2023 | - | -$4.91 M(-69.3%) | -$49.34 M(-21.9%) |
| June 2023 | - | -$15.98 M(+20.4%) | -$63.21 M(-4.4%) |
| Mar 2023 | - | -$13.28 M(-12.5%) | -$66.14 M(-19.3%) |
| Dec 2022 | -$81.94 M(-28.8%) | -$15.17 M(-19.2%) | -$81.94 M(-28.8%) |
| Sept 2022 | - | -$18.78 M(-0.7%) | -$115.04 M(-4.6%) |
| June 2022 | - | -$18.92 M(-34.9%) | -$120.62 M(-5.4%) |
| Mar 2022 | - | -$29.07 M(-39.8%) | -$127.49 M(+10.7%) |
| Dec 2021 | -$115.16 M(+37.8%) | -$48.27 M(+98.2%) | -$115.16 M(+33.5%) |
| Sept 2021 | - | -$24.36 M(-5.5%) | -$86.23 M(+14.0%) |
| June 2021 | - | -$25.79 M(+54.0%) | -$75.61 M(+5.0%) |
| Mar 2021 | - | -$16.74 M(-13.5%) | -$72.03 M(-13.8%) |
| Dec 2020 | -$83.55 M | -$19.34 M(+40.7%) | -$83.55 M(-13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$13.74 M(-38.1%) | -$97.00 M(-14.4%) |
| June 2020 | - | -$22.20 M(-21.4%) | -$113.34 M(-9.5%) |
| Mar 2020 | - | -$28.25 M(-13.9%) | -$125.20 M(+2.3%) |
| Dec 2019 | -$122.38 M(+106.2%) | -$32.80 M(+9.0%) | -$122.38 M(+11.4%) |
| Sept 2019 | - | -$30.08 M(-11.7%) | -$109.89 M(+16.0%) |
| June 2019 | - | -$34.06 M(+33.9%) | -$94.75 M(+29.7%) |
| Mar 2019 | - | -$25.44 M(+25.2%) | -$73.05 M(+23.1%) |
| Dec 2018 | -$59.34 M(+122.9%) | -$20.31 M(+35.9%) | -$59.34 M(+23.0%) |
| Sept 2018 | - | -$14.94 M(+20.9%) | -$48.24 M(+18.0%) |
| June 2018 | - | -$12.36 M(+5.3%) | -$40.87 M(+21.2%) |
| Mar 2018 | - | -$11.73 M(+27.4%) | -$33.71 M(+26.6%) |
| Dec 2017 | -$26.63 M(+101.3%) | -$9.21 M(+21.6%) | -$26.63 M(+52.9%) |
| Sept 2017 | - | -$7.57 M(+45.6%) | -$17.42 M(+76.9%) |
| June 2017 | - | -$5.20 M(+11.8%) | -$9.85 M(+111.8%) |
| Mar 2017 | - | -$4.65 M | -$4.65 M |
| Dec 2016 | -$13.23 M | - | - |
FAQ
- What is Xeris Biopharma Holdings annual operaing income?
- What is the all time high annual operating profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual operating profit year-on-year change?
- What is Xeris Biopharma Holdings quarterly operating income?
- What is the all time high quarterly operating profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly operating profit year-on-year change?
- What is Xeris Biopharma Holdings TTM operating income?
- What is the all time high TTM operating profit for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM operating profit year-on-year change?
What is Xeris Biopharma Holdings annual operaing income?
The current annual operating profit of XERS is -$44.01 M
What is the all time high annual operating profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual operaing income is -$13.23 M
What is Xeris Biopharma Holdings annual operating profit year-on-year change?
Over the past year, XERS annual operaing income has changed by +$37.93 M (+46.29%)
What is Xeris Biopharma Holdings quarterly operating income?
The current quarterly operating profit of XERS is -$12.89 M
What is the all time high quarterly operating profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly operating income is -$4.65 M
What is Xeris Biopharma Holdings quarterly operating profit year-on-year change?
Over the past year, XERS quarterly operating income has changed by -$7.98 M (-162.43%)
What is Xeris Biopharma Holdings TTM operating income?
The current TTM operating profit of XERS is -$45.17 M
What is the all time high TTM operating profit for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM operating income is -$4.65 M
What is Xeris Biopharma Holdings TTM operating profit year-on-year change?
Over the past year, XERS TTM operating income has changed by +$4.17 M (+8.46%)